Evidence map›Paper›PMID 23632297›Full record

ArticleThe Journal of allergy and clinical immunology2013

Compartmentalized chemokine-dependent regulatory T-cell inhibition of allergic pulmonary inflammation.

Roshi Afshar, James P Strassner, Edward Seung, Benjamin Causton, Josalyn L Cho, R Scott Harris, Daniel L Hamilos, Benjamin D Medoff, Andrew D Luster

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Shared DNA methylation signatures in childhood allergy: The MeDALL study.The Journal of allergy and clinical immunology · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Enhanced antigen presenting and T cell functions during late-phase allergic responses in the lung.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  14. Lung-Infiltrating Foxp3Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  15. Article
  16. Effect of follicular helper T cells on the pathogenesis of asthma.Experimental and therapeutic medicine · 2017
    Article
  17. Regulatory T Cells in Allergy and Asthma.Frontiers in pediatrics · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Roshi AfsharCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
James P Strassner
Edward Seung
Benjamin Causton
Josalyn L Cho
R Scott Harris
Daniel L Hamilos
Benjamin D Medoff
Andrew D Luster
Harvard University · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Tetramer CoreU19AI095261 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 2011 to 2015
$10.8M
Chemokines and Th2 Cell Trafficking in AsthmaR37AI040618 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 2008 to 2017
$4.0M
Research Training in Allergy and Immunology at Massachusetts General HospitalT32AI060548 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 2006 to 2010
$799k
NIAID NIH HHS R37AI0406NIAID NIH HHS R37 AI040618NIAID NIH HHS T32 AI060548NIAID NIH HHS U19 AI095261NIAID NIH HHS U19AI095261NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

backgroundInduction of endogenous regulatory T (Treg) cells represents an exciting new potential modality for treating allergic diseases, such as asthma. Treg cells have been implicated in the regulation of asthma, but the anatomic location in which they exert their regulatory function and the mechanisms controlling the migration necessary for their suppressive function in asthma are not known. Understanding these aspects of Treg cell biology will be important for harnessing their power in the clinic.

objectiveWe sought to determine the anatomic location at which Treg cells exert their regulatory function in the sensitization and effector phases of allergic asthma and to determine the chemokine receptors that control the migration of Treg cells to these sites in vivo in both mice and human subjects.

methodsThe clinical efficacy and anatomic location of adoptively transferred chemokine receptor-deficient CD4(+)CD25(+) forkhead box protein 3-positive Treg cells was determined in the sensitization and effector phases of allergic airway inflammation in mice. The chemokine receptor expression profile was determined on Treg cells recruited into the human airway after bronchoscopic segmental allergen challenge of asthmatic patients.

resultsWe show that CCR7, but not CCR4, is required on Treg cells to suppress allergic airway inflammation during the sensitization phase. In contrast, CCR4, but not CCR7, is required on Treg cells to suppress allergic airway inflammation during the effector phase. Consistent with our murine studies, human subjects with allergic asthma had an increase in CCR4-expressing functional Treg cells in the lungs after segmental allergen challenge.

conclusionThe location of Treg cell function differs during allergic sensitization and allergen-induced recall responses in the lung, and this differential localization is critically dependent on differential chemokine function.

Indexed as

AllergensAnimalsAsthmaBronchoalveolar Lavage FluidCell MovementChemokinesDisease Models, AnimalGene ExpressionGene Knockout TechniquesHumansImmunizationInflammationLungMiceReceptors, CCR4Receptors, CCR7AllergensChemokinesReceptors, CCR4Receptors, CCR7

Identifiers

PMID23632297
PMCPMC3703653
OpenAlexW1986053742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.